Vaccine Education Center

In the News

This section contains links to information about vaccines that was recently in the news: 

CDC reports an early start to flu season

According to the Centers for Disease Control and Prevention (CDC), influenza season is starting early this year with all 50 states, Guam and the District of Columbia reporting some level of influenza activity. Five people have died so far from influenza-related complications. This influenza season is expected to be more severe because one of the types of influenza virus circulating, known as H3N2, typically causes more severe symptoms. The good news is that the current seasonal influenza vaccine seems to be a good match with the types of influenza viruses that are circulating.

Additional information:

Media coverage:

Pertussis vaccine: The best way to prevent whooping cough

Pertussis, or whooping cough, continues to run rampant across the United States with the highest number of cases being reported since 1959. As of December 1, 2012, more than 38,000 cases of whooping cough and 16 whooping-cough-associated deaths have been reported to the CDC.

Children less than 3 months old are at high risk of complications and death from whooping cough, and a majority of the deaths associated with the current outbreak occurred in this age group. Seven of 10 of these occurred after the infants got pertussis from a parent. To address this, public health officials have been recommending a method called “cocooning,” urging parents and grandparents to get a dose of the Tdap vaccine. Recently, the recommendation for pregnant women has gone even further:

Recent data stemming from the outbreak has also shown that the current pertussis vaccine, known as the “acellular” pertussis vaccine, does not provide protection as robust as a previous version, known as the “whole-cell” pertussis vaccine. Because side effects were common and, sometimes severe after the "whole-cell" pertussis vaccine, researchers developed the “acellular” version, which became the recommended choice in the late 1990s. As the current outbreak has spread, public health officials have realized that immunity decreases more rapidly in adolescents who had the newer version. Despite these findings, officials continue to recommend immunization as it is still the best option for avoiding disease.

Media coverage:

UDPATE: Fungal meningitis and contaminated steroid injections

On September 26, the New England Compounding Center (NECC) voluntarily recalled three lots of a preservative-free steroid injection containing methylprednisolone acetate (80mg/mL). This medication is typically used to treat back and peripheral joint pain. The recall was implemented after fungus was detected in multiple sealed vials. Those individuals who received injections of methylprednisolone acetate (80mg/mL) from May 21, 2012 to September 26, 2012 should seek medical attention if they experience side effects associated with fungal meningitis or joint infections (see below).

Some information about current cases

Some information about fungal meningitis

Additional information

Last Updated: December 13, 2012

Materials in this section are updated as new information and vaccines become available. The Vaccine Education Center staff regularly reviews materials for accuracy.

You should not consider the information in this site to be specific, professional medical advice for your personal health or for your family's personal health. You should not use it to replace any relationship with a physician or other qualified healthcare professional. For medical concerns, including decisions about vaccinations, medications and other treatments, you should always consult your physician or, in serious cases, seek immediate assistance from emergency personnel.

 

  • Print
  • Share

Contact Us

We would like to hear from you. Please use our online form to contact us with questions or comments.